NLM Logo

rovalpituzumab tesirine MeSH Supplementary Concept Data 2025


MeSH Supplementary
rovalpituzumab tesirine
Unique ID
C000620223
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000620223
Entry Term(s)
SC16LD6.5
Registry Numbers
0
Heading Mapped to
*Benzodiazepinones
*Immunoconjugates
*Antibodies, Monoclonal, Humanized
Frequency
27
Note
targets delta-like protein 3; consists of SC16 monoclonal antibody linked to the DNA cross-linking agent SC-DR002
Source
Lancet Oncol. 2016 Jan;18(1):42-51.
Date of Entry
2017/06/11
Revision Date
2017/06/11
rovalpituzumab tesirine Preferred
SC16LD6.5 Narrower
page delivered in 0.003s